Reglan Failure-To-Warn Suit Brought To Supreme Court

Law360, Washington (March 1, 2012, 5:05 PM EST) -- Three individuals who developed a neurological disorder after taking generic versions of heartburn medication Reglan told the U.S. Supreme Court last month that the Hatch-Waxman Amendments should not preempt their state failure-to-warn claims against makers of generic Reglan.

Alice Wilson, Dennis Morris and Lala Smith are appealing the Sixth Circuit's September ruling that a Kentucky federal judge had correctly nixed their suits in 2008 because the claims against the generics makers were preempted by federal law and the claims against the brand-name producers weren't viable under...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.